Association between antibody response to SARS-CoV-2 and progression to critically severe disease in a cohort of patients with vaccine breakthrough COVID-19
COVID-19 ECCMID 2022
[00:04:04]
23 April 2022
-
PS086
Antibody response to SARS-CoV-2 in patients hospitalised with vaccine breakthrough COVID-19 during the Delta and Omicron waves
COVID-19 ECCMID 2022
[00:04:51]
23 April 2022
-
PS086
SARS-CoV-2 neutralising antibodies in Irish healthcare workers prior to booster COVID-19 vaccination
COVID-19 ECCMID 2022
[00:04:36]
23 April 2022
-
PS086
Neutralising antibody levels and viral load during and following COVID-19 hospitalisation: a prospective cohort study
COVID-19 ECCMID 2022
[00:05:08]
23 April 2022
-
PS086
Durability of SARS-CoV-2 antibodies and risk-factors for SARS-CoV-2 infection in Irish healthcare workers in the era of booster COVID-19 vaccination
COVID-19 ECCMID 2022
[00:04:47]
23 April 2022
-
PS086
Temporal dynamics of the host immune response predictive of disease severity and progression in patients hospitalised for COVID-19
COVID-19 ECCMID 2022
[00:04:56]
23 April 2022
-
PS086
Impact of SARS-CoV-2 RNAemia on prognosis of immunocompetent adults and solid organ transplant recipients with COVID-19
COVID-19 ECCMID 2022
[00:03:00]
23 April 2022
-
PS086
Real-world evidence highlights the usefulness of the anti-SARS-CoV-2 N and S immunoassays in determining antibody responses and immune protection after natural infection and vaccination
COVID-19 ECCMID 2022
[00:04:38]
23 April 2022
-
PS086
Glycine decarboxylase (GLDC) inhibition by cysteamine, a phase III clinical candidate intervention for community-acquired pneumonia (CAP), potentiates the host response to respiratory viruses, including SARS-CoV-2, via pyrimidine restriction
COVID-19 ECCMID 2022
[00:04:26]
23 April 2022
-
PS086
Early T cell specific response in household contacts exposed to COVID-19 patients
COVID-19 ECCMID 2022
[00:04:54]
23 April 2022
-
PS086
Hyperinflammatory state and low T1 adaptive immune response in severe and critical acute COVID-19 patients
COVID-19 ECCMID 2022
[00:05:15]
23 April 2022
-
PS086
QuantiFERON® SARS-CoV-2 and total spike antibody tests in immunocompetent adults and kidney transplant patients after two mRNA vaccine doses
COVID-19 ECCMID 2022
[00:03:57]
23 April 2022
-
PS086
A longitudinal follow-up study of SARS-CoV-2 antibody persistence
COVID-19 ECCMID 2022
[00:03:32]
23 April 2022
-
PS086
Analysis of serum interferon-? and interferon-? levels in immunocompetent adults and solid organ transplant recipients with COVID-19
COVID-19 ECCMID 2022
[00:03:27]
23 April 2022
-
PS086
Comparison of three collection modes to assess antibody response to SARS-CoV-2 mRNA vaccines in saliva
COVID-19 ECCMID 2022
[00:02:46]
23 April 2022
-
PS086
Cytokines, calgranulins and specific antibodies in breast milk of mothers after SARS-coV-2 infection
COVID-19 ECCMID 2022
[00:02:33]
23 April 2022
-
PS086
Hybrid immunisation induces a stronger long-lasting humoral and T cell immunity compared to unvaccinated convalescent patients and naïve vaccinated subjects
COVID-19 ECCMID 2022
[00:04:59]
23 April 2022
-
PS086
Impact on HIV-1 RNA levels and antibody responses following SARS-CoV-2 vaccination in HIV-infected individuals
COVID-19 ECCMID 2022
[00:04:02]
23 April 2022
-
PS086
Monitoring the humoral immune response elicited by COVID-19 vaccines
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.